TradingKey

關於 Inspire Medical Systems Inc 公司

Inspire Medical Systems, Inc. 是一家醫療技術公司。該公司專注於爲阻塞性睡眠呼吸暫停 (OSA) 患者開發和商業化先進的微創解決方案。其專有的 Inspire 療法是經 FDA 批准的神經刺激技術，可爲中度至重度阻塞性睡眠呼吸暫停提供安全有效的治療。該公司開發了一種新穎的閉環解決方案，可以持續監測患者的呼吸並提供輕度舌下神經刺激以保持氣道暢通。該公司通過直銷組織向美國 (US) 和歐洲和日本部分國家的醫院和門診手術中心 (ASC) 銷售其 Inspire 系統，並通過分銷商在新加坡和香港銷售其 Inspire 系統。其直銷團隊從事針對耳鼻喉 (ENT) 醫生和睡眠中心的銷售工作和促銷活動。

公司簡介

公司代碼INSP

公司名稱Inspire Medical Systems Inc

上市日期May 03, 2018

CEOMr. Timothy P. (Tim) Herbert

員工數量1246

證券類型Ordinary Share

年結日May 03

公司地址5500 Wayzata Blvd Ste 1600

城市GOLDEN VALLEY

上市交易所NYSE Consolidated

國家United States of America

郵編55416-1237

電話17639575037

網址https://www.inspiresleep.com/

公司代碼INSP

上市日期May 03, 2018

CEOMr. Timothy P. (Tim) Herbert

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Timothy P. (Tim) Herbert

Chairman of the Board, President, Chief Executive Officer

77.13K

-79.27%

Mr. Shawn T. Mccormick

Independent Director

31.05K

+14.79%

Mr. Casey M. Tansey

Independent Director

23.01K

+0.58%

Mr. Bryan K. Phillips, J.D.

Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

6.36K

-43.33%

Mr. Jason P. Kelly

Chief Manufacturing and Quality Officer

4.54K

--

Ms. Shelley G. Broader

Independent Director

4.12K

+3.72%

Dr. Myriam J. Curet, M.D.

Independent Director

3.37K

+60.29%

Mr. John C. Rondoni

Chief Technology Officer

--

Mr. Carlton W. Weatherby

Chief Strategy and Growth Officer

--

Ms. Georgia Garinoismelenikiotou

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Timothy P. (Tim) Herbert

Chairman of the Board, President, Chief Executive Officer

77.13K

-79.27%

Mr. Shawn T. Mccormick

Independent Director

31.05K

+14.79%

Mr. Casey M. Tansey

Independent Director

23.01K

+0.58%

Mr. Bryan K. Phillips, J.D.

Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

6.36K

-43.33%

Mr. Jason P. Kelly

Chief Manufacturing and Quality Officer

4.54K

--

Ms. Shelley G. Broader

Independent Director

4.12K

+3.72%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

193.61M

96.17%

All other countries

7.71M

3.83%

業務

地區

暫無數據

股東統計

更新時間: 5月20日週二

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.20%

The Vanguard Group, Inc.

10.91%

Fidelity Management & Research Company LLC

6.86%

Wasatch Global Investors Inc

5.17%

Dragoneer Investment Group, LLC

4.40%

Other

60.46%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.20%

The Vanguard Group, Inc.

10.91%

Fidelity Management & Research Company LLC

6.86%

Wasatch Global Investors Inc

5.17%

Dragoneer Investment Group, LLC

4.40%

Other

60.46%

股東類型

持股股東

佔比

Investment Advisor

66.57%

Investment Advisor/Hedge Fund

34.59%

Hedge Fund

6.84%

Private Equity

4.40%

Pension Fund

2.68%

Research Firm

2.40%

Individual Investor

1.24%

Bank and Trust

0.83%

Venture Capital

0.30%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

879

35.51M

120.38%

-5.57M

2025Q1

912

35.71M

121.08%

-5.66M

2024Q4

874

35.22M

118.69%

-4.72M

2024Q3

852

35.48M

118.45%

-2.86M

2024Q2

825

33.60M

112.73%

-2.85M

2024Q1

801

33.20M

111.87%

-2.01M

2023Q4

786

32.35M

109.45%

+751.92K

2023Q3

753

29.93M

101.80%

-635.63K

2023Q2

727

29.57M

101.94%

-987.85K

2023Q1

680

29.78M

102.13%

-573.41K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

3.60M

12.2%

-96.27K

-2.61%

Mar 31, 2025

The Vanguard Group, Inc.

3.22M

10.91%

-44.71K

-1.37%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.02M

6.86%

-48.18K

-2.33%

Mar 31, 2025

Wasatch Global Investors Inc

1.52M

5.17%

+202.34K

+15.31%

Mar 31, 2025

Dragoneer Investment Group, LLC

1.30M

4.4%

+426.49K

+48.96%

Mar 31, 2025

Baillie Gifford & Co.

1.16M

3.93%

-96.25K

-7.66%

Mar 31, 2025

State Street Global Advisors (US)

1.01M

3.42%

-54.09K

-5.09%

Mar 31, 2025

Invesco Advisers, Inc.

802.47K

2.72%

+66.89K

+9.09%

Mar 31, 2025

William Blair Investment Management, LLC

692.92K

2.35%

-209.69K

-23.23%

Mar 31, 2025

UBS Asset Management (Switzerland)

659.44K

2.24%

+352.82K

+115.07%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Global X HealthTech ETF

3.07%

Invesco S&P SmallCap Health Care ETF

2.74%

BNY Mellon Innovators ETF

2.18%

Fidelity Digital Health ETF

1.91%

SPDR S&P Health Care Equipment ETF

1.78%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.41%

ETC 6 Meridian Small Cap Equity ETF

0.82%

Invesco S&P SmallCap 600 Pure Growth ETF

0.6%

Harbor Long-Short Equity ETF

0.58%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.56%

Global X HealthTech ETF

佔比3.07%

Invesco S&P SmallCap Health Care ETF

佔比2.74%

BNY Mellon Innovators ETF

佔比2.18%

Fidelity Digital Health ETF

佔比1.91%

SPDR S&P Health Care Equipment ETF

佔比1.78%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比1.41%

ETC 6 Meridian Small Cap Equity ETF

佔比0.82%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.6%

Harbor Long-Short Equity ETF

佔比0.58%

Vanguard S&P Small-Cap 600 Growth Index Fund

佔比0.56%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Inspire Medical Systems Inc

128.160USD

Inspire Medical Systems Inc

128.160

概覽

公司

財務